5-Year Survival Update From KEYNOTE-010: Pembrolizumab Versus Docetaxel in Previously Treated, PD-L1-Positive Advanced NSCLC

Herbst, R; Garon, E; Kim, D; Cho, BC; Gervais, R; Perez-Gracia, JL; Han, J; Majem, M; Forster, MD; Monnet, I; Novello, S; Gubens, MA; Boyer, M; Su, W; Samkari, A; Jensen, EH; Piperdi, B; Baas, P

JOURNAL OF THORACIC ONCOLOGY, 2021; 16 (3): S223

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索